Jim Simons
ICCC icon

Jim Simons’s ImmuCell ICCC Stock Holding History

Jim Simons’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$961K Buy
151,789
+1,100
+0.7% +$7.04K ﹤0.01% 2295
2025
Q4 		$927K Sell
150,689
-6,600
-4% -$38.9K ﹤0.01% 2328
2025
Q3 		$983K Sell
157,289
-2,700
-2% -$17.1K ﹤0.01% 2491
2025
Q2 		$1.11M Buy
159,989
+26,000
+19% +$152K ﹤0.01% 2460
2025
Q1 		$642K Sell
133,989
-3,000
-2% -$15.4K ﹤0.01% 2636
2024
Q4 		$705K Sell
136,989
-12,500
-8% -$49.8K ﹤0.01% 2677
2024
Q3 		$543K Buy
149,489
+23,900
+19% +$92.9K ﹤0.01% 2756
2024
Q2 		$609K Buy
125,589
+700
+0.6% +$3.37K ﹤0.01% 2604
2024
Q1 		$662K Sell
124,889
-1,300
-1% -$6.7K ﹤0.01% 2738
2023
Q4 		$642K Buy
126,189
+4,809
+4% +$23.5K ﹤0.01% 2664
2023
Q3 		$648K Sell
121,380
-1,009
-0.8% -$5.12K ﹤0.01% 2592
2023
Q2 		$612K Sell
122,389
-438
-0.4% -$2.24K ﹤0.01% 2756
2023
Q1 		$633K Sell
122,827
-2,662
-2% -$17.3K ﹤0.01% 2757
2022
Q4 		$765K Sell
125,489
-12,097
-9% -$87.3K ﹤0.01% 2687
2022
Q3 		$1.03M Sell
137,586
-16,201
-11% -$132K ﹤0.01% 2479
2022
Q2 		$1.34M Sell
153,787
-792
-0.5% -$6.87K ﹤0.01% 2511
2022
Q1 		$1.49M Sell
154,579
-13,037
-8% -$113K ﹤0.01% 2442
2021
Q4 		$1.34M Sell
167,616
-8,706
-5% -$77.8K ﹤0.01% 2440
2021
Q3 		$1.65M Sell
176,322
-1,834
-1% -$17.4K ﹤0.01% 2234
2021
Q2 		$1.69M Sell
178,156
-9,422
-5% -$91.9K ﹤0.01% 2373
2021
Q1 		$1.81M Buy
187,578
+19,425
+12% +$182K ﹤0.01% 2291
2020
Q4 		$1M Buy
168,153
+12,031
+8% +$70.1K ﹤0.01% 2497
2020
Q3 		$848K Buy
156,122
+18,450
+13% +$102K ﹤0.01% 2594
2020
Q2 		$651K Buy
137,672
+19,800
+17% +$86.3K ﹤0.01% 2767
2020
Q1 		$447K Buy
117,872
+7,766
+7% +$38.2K ﹤0.01% 2812
2019
Q4 		$567K Buy
110,106
+14,000
+15% +$72.2K ﹤0.01% 2852
2019
Q3 		$535K Buy
96,106
+4,100
+4% +$24K ﹤0.01% 2848
2019
Q2 		$598K Buy
92,006
+700
+0.8% +$4.44K ﹤0.01% 2920
2019
Q1 		$580K Sell
91,306
-500
-0.5% -$3.57K ﹤0.01% 2877
2018
Q4 		$647K Sell
91,806
-4,294
-4% -$33.2K ﹤0.01% 2766
2018
Q3 		$801K Buy
96,100
+2,500
+3% +$18K ﹤0.01% 2693
2018
Q2 		$638K Buy
93,600
+1,500
+2% +$10.8K ﹤0.01% 2762
2018
Q1 		$645K Sell
92,100
-1,800
-2% -$13.2K ﹤0.01% 2824
2017
Q4 		$825K Sell
93,900
-4,300
-4% -$35.2K ﹤0.01% 2737
2017
Q3 		$638K Buy
98,200
+18,300
+23% +$120K ﹤0.01% 2725
2017
Q2 		$586K Buy
79,900
+2,800
+4% +$16.6K ﹤0.01% 2722
2017
Q1 		$426K Sell
77,100
-9,100
-11% -$52.3K ﹤0.01% 2813
2016
Q4 		$513K Buy
86,200
+12,900
+18% +$78.5K ﹤0.01% 2753
2016
Q3 		$567K Buy
73,300
+9,100
+14% +$66.2K ﹤0.01% 2772
2016
Q2 		$443K Buy
64,200
+7,493
+13% +$50.6K ﹤0.01% 2835
2016
Q1 		$388K Buy
56,707
+8,907
+19% +$59.4K ﹤0.01% 2914
2015
Q4 		$360K Buy
47,800
+2,600
+6% +$18.3K ﹤0.01% 2831
2015
Q3 		$269K Buy
45,200
+17,500
+63% +$143K ﹤0.01% 2805
2015
Q2 		$217K Buy
27,700
+6,100
+28% +$41.9K ﹤0.01% 2963
2015
Q1 		$136K Buy
21,600
+2,400
+13% +$15.1K ﹤0.01% 2965
2014
Q4 		$93K Buy
19,200
+1,400
+8% +$6.67K ﹤0.01% 2813
2014
Q3 		$88K Buy
17,800
+2,300
+15% +$10.8K ﹤0.01% 2678
2014
Q2 		$68K Buy
15,500
+1,800
+13% +$7.58K ﹤0.01% 2694
2014
Q1 		$66K Buy
13,700
+1,300
+10% +$5.66K ﹤0.01% 2742
2013
Q4 		$53K Buy
12,400
+1,400
+13% +$6.06K ﹤0.01% 2781
2013
Q3 		$52K Buy
11,000
+1,000
+10% +$3.91K ﹤0.01% 2739
2013
Q2 		$38K Buy
+10,000
New +$35.8K ﹤0.01% 2713

Other funds holding ICCC

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
S
Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jim Simons's ICCC Position: Q1 2026 in Review

Jim Simons increased its ImmuCell (ICCC) stake by 0.73% in Q1 2026, buying an estimated $7.04K and bringing the position to 151,789 shares worth $961K. The position accounts for ﹤0.01% of the portfolio, ranked #2295.

Jim Simons first reported a position in ICCC in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.81M in Q1 2021. 27 funds tracked by Wall St. Rank hold ICCC as of Q1 2026.

  • Jim Simons held 151,789 shares of ImmuCell worth $961K as of Q1 2026.
  • Jim Simons bought 1,100 ImmuCell shares in Q1 2026, an estimated $7.04K.
  • ImmuCell made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2295 holding.
  • Jim Simons first reported a position in ImmuCell in Q2 2013 and has held it in 52 quarters since.
  • Jim Simons's ImmuCell position peaked at $1.81M in Q1 2021.
  • 27 funds tracked by Wall St. Rank held ImmuCell as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.